Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
SAGA Diagnostics Appoints Peter Collins as Chief Executive Officer
SAGA Diagnostics AB (“SAGA”), a leading cancer liquid biopsy and genomic testing company, has announced the […]
Röchling Medical and Trendlines Innovation Labs Join Forces to Offer Top Innovation and Manufacturing Expertise to the Healthcare Industry
Röchling Medical, a division of the German-based Röchling Group and a leading manufacturer for the healthcare […]
Capital Rx Adds Chief Financial Officer with Health Plan Experience
Capital Rx, a healthtech company changing the way prescription drugs are priced and patients are […]
Bayer to Invest Over €400 Million to Increase Access to Modern Contraception
Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]
Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer
Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming […]
seqWell Appoints New Commercial Team, Led by Chief Commercial Officer Steve Smith
seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing […]
C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities
C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed […]
CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments & Expand Activity in China
CoreBone, a company that produces bioactive, coral-based bone graft material, announced that it has completed an […]
Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M)
Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]
Nanoform Receives Funding to Solve Challenges for Global Health
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more